TAMBRIZA



Trademark Coverage

No Class Specified

Pharmaceutical preparations for the treatment of cardiovascular, cardiopulmonary, genitourinary, central nervous system, endocrine, gastrointestinal, gynecological, hematological, immunological, hormonal, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological, neurodegenerative and viral related diseases and disorders; pharmaceutical preparations for the treatment of pain, sepsis, diabetes, apopecia, allergies, erectile dysfunction, sexual dysfunction, obesity, and HIV/AIDS

Owner

Methylgene Inc.

Business in Montreal, CA

Owns 7 trademarks

Timeline
  • Feb 03
    2014
    Abandonment Notice Mailed No Use Statement Filed
  • Feb 03
    2014
    Abandonment No Use Statement Filed
  • Jul 27
    2013
    Notice Of Approval Of Extension Request E Mailed
  • Jul 26
    2013
    Extension 3 Granted
  • Jun 25
    2013
    Extension 3 Filed
  • Jul 24
    2013
    Case Assigned To Intent To Use Paralegal
  • Jun 25
    2013
    TEAS Extension Received
  • Jan 23
    2013
    Notice Of Approval Of Extension Request E Mailed
  • Jan 22
    2013
    Extension 2 Granted
  • Dec 28
    2012
    Extension 2 Filed
  • Dec 28
    2012
    TEAS Extension Received
  • Jul 18
    2012
    Notice Of Approval Of Extension Request E Mailed
  • Jul 17
    2012
    Extension 1 Granted
  • Jun 20
    2012
    Extension 1 Filed
  • Jul 16
    2012
    Case Assigned To Intent To Use Paralegal
  • Jun 20
    2012
    TEAS Extension Received
  • Jan 03
    2012
    NOA E Mailed SOU Required From Applicant
  • Nov 08
    2011
    Official Gazette Publication Confirmation E Mailed
  • Nov 08
    2011
    Published For Opposition
  • Oct 03
    2011
    Approved For PUB Principal Register
  • Oct 03
    2011
    Assigned To Examiner
  • Jun 28
    2011
    New Application Office Supplied Data Entered In TRAM
  • Jun 25
    2011
    New Application Entered In TRAM